Outlook Therapeutics, Inc. (OTLK)

0.503 -0.01 (-1.37%) USD  |  NASDAQ  |  Jan 23, 16:00
0.5044 0.00 (0.00%) After-Hours: 20:00
More

Outlook Therapeutics Change in Payables and Accrued Expense (Quarterly)

Change in Payables and Accrued Expense (Quarterly) Chart

View Change in Payables and Accrued Expense (Quarterly) for OTLK.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Change in Payables and Accrued Expense (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Change in Payables and Accrued Expense (Quarterly) Range, Past 5 Years

View Change in Payables and Accrued Expense (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Change in Payables and Accrued Expense (Quarterly) Benchmarks

View Change in Payables and Accrued Expense (Quarterly) Benchmarks
Start Trial
Ironwood Pharmaceuticals, Inc. Upgrade
Amicus Therapeutics, Inc. Upgrade
Neogen Corp. Upgrade
CorMedix, Inc. Upgrade
NovaBay Pharmaceuticals, Inc. Upgrade